Submit Search
Upload
The Stock Market Show | 13 September 2014
•
1 like
•
276 views
ANGLE plc
Follow
The Stock Market Show
Read less
Read more
Healthcare
Report
Share
Report
Share
1 of 11
Download now
Download to read offline
Recommended
Shares Investor Evening 29 October 2014
Shares Investor Evening 29 October 2014
ANGLE plc
Parsortix non-invasive cancer diagnostics | 3 September 2014
Parsortix non-invasive cancer diagnostics | 3 September 2014
ANGLE plc
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE plc
ANGLE Interim Results 2013 31jan13
ANGLE Interim Results 2013 31jan13
ANGLE plc
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc
ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13
ANGLE plc
Alpha Tau Medical presentation Uzi Sofer, January 2019
Alpha Tau Medical presentation Uzi Sofer, January 2019
Howard Sterling
Liquid Biopsy 29 January 2015
Liquid Biopsy 29 January 2015
ANGLE plc
Recommended
Shares Investor Evening 29 October 2014
Shares Investor Evening 29 October 2014
ANGLE plc
Parsortix non-invasive cancer diagnostics | 3 September 2014
Parsortix non-invasive cancer diagnostics | 3 September 2014
ANGLE plc
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE Presentation 4 February 2014 Shares Cenkos Investor Forum
ANGLE plc
ANGLE Interim Results 2013 31jan13
ANGLE Interim Results 2013 31jan13
ANGLE plc
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc 30 January 2014: Interim Results for the year ended 31 October 2013
ANGLE plc
ANGLE Peliminary Results 2013 31jul13
ANGLE Peliminary Results 2013 31jul13
ANGLE plc
Alpha Tau Medical presentation Uzi Sofer, January 2019
Alpha Tau Medical presentation Uzi Sofer, January 2019
Howard Sterling
Liquid Biopsy 29 January 2015
Liquid Biopsy 29 January 2015
ANGLE plc
Personalised Cancer Care December 2014
Personalised Cancer Care December 2014
ANGLE plc
20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken
SMBBV
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
ANGLE plc
20160126 smb m dx health jan groen
20160126 smb m dx health jan groen
SMBBV
Presentation 2 July 2015: Proactive Investors Forum
Presentation 2 July 2015: Proactive Investors Forum
ANGLE plc
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
MarketResearch.com
ANGLE shares investor evening 15 April 2015
ANGLE shares investor evening 15 April 2015
ANGLE plc
Aridis Investor Presentation 2022 Q1
Aridis Investor Presentation 2022 Q1
RedChip Companies, Inc.
SCIE Investor Presentation January 2017
SCIE Investor Presentation January 2017
Mike Oliver
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
ANGLE plc
PharmAust Limited - ASX: PAA
PharmAust Limited - ASX: PAA
RedChip Companies, Inc.
Imugene Limited - ASX: IMU
Imugene Limited - ASX: IMU
RedChip Companies, Inc.
How to Pick the Right OCT eBook
How to Pick the Right OCT eBook
Haag-Streit UK (HS-UK)
Imugene Corporate Presentation
Imugene Corporate Presentation
RedChip Companies, Inc.
Student Health Insurance Plan
Student Health Insurance Plan
ucsfstudenthealth
10 rtgn
10 rtgn
RedChip Companies, Inc.
Vidyo helped REACH Health Effectively Handle Emergency Care
Vidyo helped REACH Health Effectively Handle Emergency Care
Vidyo, Inc.
Scythian investor Presentation ppt
Scythian investor Presentation ppt
RedChip Companies, Inc.
Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014
Stanford University
Stark Update
Stark Update
Polsinelli PC
ASCO-2022-IR-Presentation.pdf
ASCO-2022-IR-Presentation.pdf
MOHAMMED YASER HUSSAIN
Aura
Aura
Healthegy
More Related Content
What's hot
Personalised Cancer Care December 2014
Personalised Cancer Care December 2014
ANGLE plc
20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken
SMBBV
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
ANGLE plc
20160126 smb m dx health jan groen
20160126 smb m dx health jan groen
SMBBV
Presentation 2 July 2015: Proactive Investors Forum
Presentation 2 July 2015: Proactive Investors Forum
ANGLE plc
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
MarketResearch.com
ANGLE shares investor evening 15 April 2015
ANGLE shares investor evening 15 April 2015
ANGLE plc
Aridis Investor Presentation 2022 Q1
Aridis Investor Presentation 2022 Q1
RedChip Companies, Inc.
SCIE Investor Presentation January 2017
SCIE Investor Presentation January 2017
Mike Oliver
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
ANGLE plc
PharmAust Limited - ASX: PAA
PharmAust Limited - ASX: PAA
RedChip Companies, Inc.
Imugene Limited - ASX: IMU
Imugene Limited - ASX: IMU
RedChip Companies, Inc.
How to Pick the Right OCT eBook
How to Pick the Right OCT eBook
Haag-Streit UK (HS-UK)
Imugene Corporate Presentation
Imugene Corporate Presentation
RedChip Companies, Inc.
Student Health Insurance Plan
Student Health Insurance Plan
ucsfstudenthealth
10 rtgn
10 rtgn
RedChip Companies, Inc.
Vidyo helped REACH Health Effectively Handle Emergency Care
Vidyo helped REACH Health Effectively Handle Emergency Care
Vidyo, Inc.
Scythian investor Presentation ppt
Scythian investor Presentation ppt
RedChip Companies, Inc.
Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014
Stanford University
Stark Update
Stark Update
Polsinelli PC
What's hot
(20)
Personalised Cancer Care December 2014
Personalised Cancer Care December 2014
20160126 smb novio gendix jack schalken
20160126 smb novio gendix jack schalken
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
Liquid biopsy from a simple blood test enabling personalised cancer care | Sh...
20160126 smb m dx health jan groen
20160126 smb m dx health jan groen
Presentation 2 July 2015: Proactive Investors Forum
Presentation 2 July 2015: Proactive Investors Forum
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
Circulating Tumor Cell, Cell Free DNA, Exosome and Vesicle Cancer Diagnostic ...
ANGLE shares investor evening 15 April 2015
ANGLE shares investor evening 15 April 2015
Aridis Investor Presentation 2022 Q1
Aridis Investor Presentation 2022 Q1
SCIE Investor Presentation January 2017
SCIE Investor Presentation January 2017
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
Presentation 28 July 2015: Preliminary Results for the year ended 30 April 2015
PharmAust Limited - ASX: PAA
PharmAust Limited - ASX: PAA
Imugene Limited - ASX: IMU
Imugene Limited - ASX: IMU
How to Pick the Right OCT eBook
How to Pick the Right OCT eBook
Imugene Corporate Presentation
Imugene Corporate Presentation
Student Health Insurance Plan
Student Health Insurance Plan
10 rtgn
10 rtgn
Vidyo helped REACH Health Effectively Handle Emergency Care
Vidyo helped REACH Health Effectively Handle Emergency Care
Scythian investor Presentation ppt
Scythian investor Presentation ppt
Tomo Wavelabs I-Corps@NIH 121014
Tomo Wavelabs I-Corps@NIH 121014
Stark Update
Stark Update
Similar to The Stock Market Show | 13 September 2014
ASCO-2022-IR-Presentation.pdf
ASCO-2022-IR-Presentation.pdf
MOHAMMED YASER HUSSAIN
Aura
Aura
Healthegy
AML NCCN 2017
AML NCCN 2017
Prof. Ahmed Mohamed Badheeb
Interpace Diagnostics Investor Presentation
Interpace Diagnostics Investor Presentation
RedChip Companies, Inc.
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
GenesisCareUK
Alcidion (ASX:ALC) Investor Presentation FY16
Alcidion (ASX:ALC) Investor Presentation FY16
Alcidion Corporation
Alcidion Product Overview Webinar
Alcidion Product Overview Webinar
Alcidion Corporation
Prescient Therapeutics Investor Presentation
Prescient Therapeutics Investor Presentation
Corey Hulls
Aao bcsc 2020-2021 13.refractive surgey
Aao bcsc 2020-2021 13.refractive surgey
Raquel Villalba Valdivia
kp.book_spreads_FINAL
kp.book_spreads_FINAL
Bob Gray
PharmAust (ASX:PAA)
PharmAust (ASX:PAA)
RedChip Companies, Inc.
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & Discovery
RedChip Companies, Inc.
Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)
roxiefoxx
Cgix presentation red chip
Cgix presentation red chip
RedChip Companies, Inc.
Gene Presentation October 2019
Gene Presentation October 2019
RedChip Companies, Inc.
Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015
Nassim Azzi, MBA
TLSA Investor Presentation August 2021
TLSA Investor Presentation August 2021
RedChip Companies, Inc.
Genetic technologies Investor Presentation
Genetic technologies Investor Presentation
RedChip Companies, Inc.
Cgix december investor-presentation
Cgix december investor-presentation
RedChip Companies, Inc.
IMS Health RWES: The Future of Real-World Insights in Cancer
IMS Health RWES: The Future of Real-World Insights in Cancer
IMSHealthRWES
Similar to The Stock Market Show | 13 September 2014
(20)
ASCO-2022-IR-Presentation.pdf
ASCO-2022-IR-Presentation.pdf
Aura
Aura
AML NCCN 2017
AML NCCN 2017
Interpace Diagnostics Investor Presentation
Interpace Diagnostics Investor Presentation
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Alcidion (ASX:ALC) Investor Presentation FY16
Alcidion (ASX:ALC) Investor Presentation FY16
Alcidion Product Overview Webinar
Alcidion Product Overview Webinar
Prescient Therapeutics Investor Presentation
Prescient Therapeutics Investor Presentation
Aao bcsc 2020-2021 13.refractive surgey
Aao bcsc 2020-2021 13.refractive surgey
kp.book_spreads_FINAL
kp.book_spreads_FINAL
PharmAust (ASX:PAA)
PharmAust (ASX:PAA)
PharmAust: A Leader In Pharmaceutical Research & Discovery
PharmAust: A Leader In Pharmaceutical Research & Discovery
Group4_Week10_Final_Business_Plan_VERSION_8(1)
Group4_Week10_Final_Business_Plan_VERSION_8(1)
Cgix presentation red chip
Cgix presentation red chip
Gene Presentation October 2019
Gene Presentation October 2019
Patient-Centered Clinical Trials 2015
Patient-Centered Clinical Trials 2015
TLSA Investor Presentation August 2021
TLSA Investor Presentation August 2021
Genetic technologies Investor Presentation
Genetic technologies Investor Presentation
Cgix december investor-presentation
Cgix december investor-presentation
IMS Health RWES: The Future of Real-World Insights in Cancer
IMS Health RWES: The Future of Real-World Insights in Cancer
Recently uploaded
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Sheetaleventcompany
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Mumbai Call girl
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Sheetaleventcompany
❤️Chandigarh Escort Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ C...
❤️Chandigarh Escort Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ C...
Sheetaleventcompany
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Sheetaleventcompany
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Sheetaleventcompany
The Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's Diagram
MedicoseAcademics
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Escorts In Kolkata
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
Rashmi Entertainment
❤️Chandigarh Escort Service☎️9815457724☎️ Call Girl service in Chandigarh☎️ C...
❤️Chandigarh Escort Service☎️9815457724☎️ Call Girl service in Chandigarh☎️ C...
Rashmi Entertainment
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
India Call Girls
Call Girl In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indor...
Call Girl In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indor...
Sheetaleventcompany
❤️ Zirakpur Call Girl Service ☎️9878799926☎️ Call Girl service in Zirakpur ☎...
❤️ Zirakpur Call Girl Service ☎️9878799926☎️ Call Girl service in Zirakpur ☎...
daljeetkaur2026
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
India Call Girls
💸Cash Payment No Advance Call Girls Kolkata 🧿 9332606886 🧿 High Class Call Gi...
💸Cash Payment No Advance Call Girls Kolkata 🧿 9332606886 🧿 High Class Call Gi...
India Call Girls
mental health , characteristic of mentally healthy person .pptx
mental health , characteristic of mentally healthy person .pptx
Pupayumnam1
💸Cash Payment No Advance Call Girls Pune 🧿 9332606886 🧿 High Class Call Girl ...
💸Cash Payment No Advance Call Girls Pune 🧿 9332606886 🧿 High Class Call Girl ...
India Call Girls
Low Rate Call Girls Goa {9xx000xx09} ❤️VVIP NISHA CCall Girls in Goa Escort s...
Low Rate Call Girls Goa {9xx000xx09} ❤️VVIP NISHA CCall Girls in Goa Escort s...
Sheetaleventcompany
2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology
Sidney Erwin Manahan
Low Rate Call Girls Pune {9xx000xx09} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9xx000xx09} ❤️VVIP NISHA Call Girls in Pune Maharas...
Sheetaleventcompany
Recently uploaded
(20)
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Independent Call Girls Service Chandigarh Sector 17 | 8868886958 | Call Girl ...
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Ulhasnagar Call girl escort *88638//40496* Call me monika call girls 24*
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
Indore Call Girl Service 📞9235973566📞Just Call Inaaya📲 Call Girls In Indore N...
❤️Chandigarh Escort Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ C...
❤️Chandigarh Escort Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ C...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Gorgeous Call Girls In Pune {9xx000xx09} ❤️VVIP ANKITA Call Girl in Pune Maha...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
Low Rate Call Girls Jaipur {9521753030} ❤️VVIP NISHA CCall Girls in Jaipur Es...
The Events of Cardiac Cycle - Wigger's Diagram
The Events of Cardiac Cycle - Wigger's Diagram
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
Call Girls Service Amritsar Just Call 9352988975 Top Class Call Girl Service ...
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
❤️ Call Girls service In Panchkula☎️9815457724☎️ Call Girl service in Panchku...
❤️Chandigarh Escort Service☎️9815457724☎️ Call Girl service in Chandigarh☎️ C...
❤️Chandigarh Escort Service☎️9815457724☎️ Call Girl service in Chandigarh☎️ C...
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
💞 Safe And Secure Call Girls Mysore 🧿 9332606886 🧿 High Class Call Girl Servi...
Call Girl In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indor...
Call Girl In Indore 📞9235973566📞Just Call Inaaya📲 Call Girls Service In Indor...
❤️ Zirakpur Call Girl Service ☎️9878799926☎️ Call Girl service in Zirakpur ☎...
❤️ Zirakpur Call Girl Service ☎️9878799926☎️ Call Girl service in Zirakpur ☎...
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
💞 Safe And Secure Call Girls Coimbatore 🧿 9332606886 🧿 High Class Call Girl S...
💸Cash Payment No Advance Call Girls Kolkata 🧿 9332606886 🧿 High Class Call Gi...
💸Cash Payment No Advance Call Girls Kolkata 🧿 9332606886 🧿 High Class Call Gi...
mental health , characteristic of mentally healthy person .pptx
mental health , characteristic of mentally healthy person .pptx
💸Cash Payment No Advance Call Girls Pune 🧿 9332606886 🧿 High Class Call Girl ...
💸Cash Payment No Advance Call Girls Pune 🧿 9332606886 🧿 High Class Call Girl ...
Low Rate Call Girls Goa {9xx000xx09} ❤️VVIP NISHA CCall Girls in Goa Escort s...
Low Rate Call Girls Goa {9xx000xx09} ❤️VVIP NISHA CCall Girls in Goa Escort s...
2024 PCP #IMPerative Updates in Rheumatology
2024 PCP #IMPerative Updates in Rheumatology
Low Rate Call Girls Pune {9xx000xx09} ❤️VVIP NISHA Call Girls in Pune Maharas...
Low Rate Call Girls Pune {9xx000xx09} ❤️VVIP NISHA Call Girls in Pune Maharas...
The Stock Market Show | 13 September 2014
1.
The Stock Market
Show Parsortix non-invasive cancer diagnostics Andrew Newland 13 September 2014
2.
© ANGLE plc
2014 Page 2 Legal disclaimer The information and opinions contained in this presentation are provided as at the date hereof and are subject to amendment (without notice), verification and completeness. This document is being supplied to you solely for your information and may not be reproduced, redistributed or passed on, directly or indirectly, to any other person or published in whole or in part for any purpose. This document is being provided to recipients on the basis that they keep confidential any information contained herein or otherwise made available, whether orally or in writing, in connection with the Company. Neither this document or any part of this document nor any copy of it may be sent to or taken into the United States of America, Canada, Australia, Japan, the Republic of South Africa or the Republic of Ireland, nor may it be distributed to, directly or indirectly, to any US person (within the meaning of regulation S promulgated under the United States Securities Act of 1933, (as amended) (the “US Securities Act”)). This document does not constitute an offer to buy or to subscribe for, or the solicitation of an offer to buy or to subscribe for securities in the Company. To the extent this document is received or used in jurisdictions outside the UK, any such recipient or user should inform themselves about and observe any applicable legal requirements. Neither this document nor any part of this document should be copied or distributed by recipients and, in particular, should not be distributed by any means, including electronic transmission, to persons with addresses in the United States of America (or any of its territories or possessions) Canada, Australia, Japan, the Republic of South Africa or the Republic of Ireland or to any citizens, residents or nationals thereof, or to any corporation, partnership or other entity created or organised under the laws thereof or in any other country outside the United Kingdom where such distribution may lead to a breach of any law or regulatory requirement. Any such distribution could result in violation of the laws of such countries. This document does not constitute or form any part of any offer or invitation or other solicitation or recommendation to purchase any securities in the Company and does not constitute or form part of a prospectus. No reliance may be placed for any purpose whatsoever on the information, representation or opinions. This document should not be considered as the giving of investment advice by the Company or any of its shareholders, directors, officers, agents, employees or advisers. Each party to whom this document is made available must make its own independent assessment of the Company after making such investigations and taking such advice as may be deemed necessary. In particular, any estimates or projections or opinions contained herein necessarily involve significant elements of subjective judgment, analysis and assumptions and each recipient should satisfy itself in relation to such matters. Neither the Company nor any other person makes any guarantee, representation or warranty, express or implied, as to the accuracy, completeness or fairness of the information and opinions contained in this document, nor does the Company accept any responsibility or liability whatsoever for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection therewith. Forward-Looking Statements This presentation and the associated commentary contains certain forward-looking statements based on current expectations, forecasts and assumptions that involve significant risks and uncertainties. These statements are based on information currently available to the Company; and actual results could differ materially from those stated or implied, due to risks and uncertainties associated with its business. Forward-looking statements include statements regarding expectations, beliefs, intentions or strategies regarding the future and can be identified by forward-looking words such as “potential”, “target”, “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “should”, “will”, and “would” or similar words. ANGLE assumes no obligation to update the information included in this presentation, whether as a result of new information, future events or otherwise.
3.
© ANGLE plc
2014 Page 3 Personalised cancer care Incidence of cancer growing −14 million new cases in 2012 up from 12.7 million cases in 2008 −8.2 million deaths up from 7.6 million Characteristic of cancer is that it continually evolves and mutates −Each patient’s cancer is different −The individual patient’s cancer changes over time Effective treatment requires personalised care −Understanding patient’s cancer −Selecting drugs that target their specific cancer −Advanced analytical techniques provide the key Healthcare economic pressures −Efficient and effective use of resources Major pharma are developing much more selective drugs −Colorectal cancer KRAS+ Cetuximab −Lung cancer EGFR+ Iressa −Breast cancer HER2+ Herceptin
4.
© ANGLE plc
2014 Page 4 Obtaining cancer cells for analysis Existing approach: solid tumour biopsy Clinicians cut out the tumour and analyse the cancer cells −Breast cancer mastectomy or lumpectomy −Colorectal cancer colonoscopy tumour biopsy −Prostate cancer fine needle biopsy and prostatectomy Difficulty in accessing some tumours −Pancreatic cancer −Lung cancer −Brain cancer Repeat tumour biopsy to see how the cancer may have changed is problematic as tissue not available for excision Side effects and treatment delays New approach: “liquid biopsy” retrieve cancer cells from blood Intense medical interest in liquid biopsy Non-invasive; Repeatable; Cost effective Challenge is only one circulating tumour cell (CTC) in one billion blood cells
5.
© ANGLE plc
2014 Page 5 Parsortix system
6.
© ANGLE plc
2014 Page 6 Key Opinion Leaders ANGLE has formal research relationships with three leading UK institutions: Positive evaluation. Key advantages: −High level of capture (80-100%) and harvest (60-100%) −Does not use antibody capture −Exceptionally low WBC contamination −Harvested cells can be analysed Colorectal cancer patient validation −High CTC capture rate −Parsortix system demonstrated twice the sensitivity of currently accepted clinical practice for CTC capture Partnership to establish a Cambridge Parsortix laboratory −Bowel cancer including colorectal, pancreatic and oesophageal cancers −New drug compounds −Gene mutation analysis and next- generation sequencing (NGS)
7.
© ANGLE plc
2014 Page 7 Competitive advantages of Parsortix Parsortix patented step system is simple, effective and affordable −Captures a high proportion of CTCs −Can be used with all solid tumour cancers (including breast, prostate, lung, colorectal, pancreatic, ovarian, cervical, brain) −Captured CTCs are intact, viable and undamaged −CTCs can be harvested (recovered from system) for analysis −Purity of CTCs very high (i.e. very low background contamination from white blood cells) allowing direct molecular analysis of harvested cells System does not use antibodies to capture cells −Antibody systems miss key target cells such as mesenchymal cells −Antibody systems do not work at all for some cancers such as ovarian cancer −Antibody capture can compromise downstream molecular analysis −Antibody systems are complicated and expensive System does not use membranes to capture cells −Membrane systems can clog up and have high background contamination −Membrane systems cannot easily harvest CTCs for analysis
8.
© ANGLE plc
2014 Page 8 Commercial advantages of Parsortix FDA submission in process −Capture large cells in blood for molecular analysis −Potential to be the first FDA authorised CTC harvesting system In-house not CLIA (certified laboratory) remote service −Offer the hospitals a system that they can use in their own labs −Competitor systems very complicated and not FDA approved so can only offer a remote service No need for reimbursement codes −Our system is a lab tool and can be used immediately for treating patients −Other closed systems need a reimbursement code that will take 3-6 years to secure and be very expensive Open source with wide application −All solid cancers and all applications −Designed to work with existing medtech platforms (not to compete with them) −Clear route to market
9.
© ANGLE plc
2014 Page 9 How ANGLE intends to secure its market position Further roll-out with key opinion leaders FDA authorisation target end of Q3 2014 Sales into the research market Key opinion leader reporting Clinical applications supported by pilot studies Patient studies to support clinical applications Roll out of clinical sales Parsortix system + regulatory authorisation + clinical application + patient data + key opinion leader = $bn market
10.
© ANGLE plc
2014 Page 10 Personalised cancer care “Personalised medicine is the most exciting change in cancer treatment since the invention of chemotherapy” Professor Peter Johnson, Chief Clinician, Cancer Research UK “Personalized cancer care is the future of medicine. The faster we can develop cancer treatments that are tailored to the individual characteristics of each patient, the better we can concentrate interventions on those who will benefit the most from them and avoid the expense, side effects and emotional involvement on those who will not.” “The evaluation phase of our work is now successfully complete and we see great promise in the application of the Parsortix technology for harvesting CTCs for molecular analysis to enable personalised cancer care. We are now undertaking pilot studies using the Parsortix system in both colorectal cancer and pancreatic cancer.” Deputy and Genomics Leader within the Clinical & Experimental Pharmacology group at Cancer Research UK Manchester Institute, Ged Brady “This agreement will greatly facilitate the use of ANGLE’s Parsortix system in our research, and that of other colleagues in Cambridge. We foresee several exciting research avenues to test different applications of the Parsortix system in the diagnosis and personalised treatment of cancer.” Medical Research Council Cancer Unit Director, Professor Ashok Venkitaraman
11.
© ANGLE plc
2014 Page 11 Andrew Newland ANGLE plc 3 Frederick Sanger Road The Surrey Research Park Guildford GU2 7YD United Kingdom Tel: +44 1483 685830 Fax: +44 1483 685836 Email: andrew.newland@ANGLEplc.com Website: www.ANGLEplc.com Contact details
Download now